Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

672
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
672
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

587
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
587
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

432
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
432

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal cancer recurrence after multimodality therapy: analysis of patterns and implications on long-term survival.

Journal of thoracic disease·2026
Same author

Paraconduit hernia after esophagectomy: Impact of operative technique on its incidence and recurrence.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
Same author

Clinical Outcomes of Pre-Transplant Cardiac Prehabilitation in the ICU on Impella 5.5.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Comparison of lung function and survival in high-risk <i>vs.</i> standard risk lung volume reduction surgery patients.

Journal of thoracic disease·2026
Same author

The Use of the Split Jejunal and Colon Patch Within the Oral Cavity: A Systematic Review and Meta-Analysis.

The Journal of craniofacial surgery·2026
Same author

The additive effect of high-risk tumor features on long-term survival and recurrence in pathologic stage I non-small cell lung cancer.

The Journal of thoracic and cardiovascular surgery·2026

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

2.6K

Coagulopathy and Anticoagulation During Thoracic Surgery.

Mathew Thomas1, K Robert Shen2

  • 1Division of Cardiothoracic Surgery, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32082, USA.

Thoracic Surgery Clinics
|July 27, 2015
PubMed
Summary

Managing antithrombotic drugs before and after thoracic surgery is key to reducing bleeding and blood clots. This guide offers strategies for optimal patient care based on current guidelines.

Keywords:
BleedingPerioperative anticoagulationPerioperative antiplateletsPerioperative antithromboticsThromboembolism

More Related Videos

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

854

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

2.6K
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

854

Area of Science:

  • Cardiovascular Medicine
  • Thoracic Surgery
  • Pharmacology

Background:

  • Thoracic surgery patients often have coagulopathy and bleeding risks.
  • Chronic use of anticoagulants and antiplatelet agents complicates surgical management.
  • Balancing bleeding and clotting risks is crucial for patient outcomes.

Purpose of the Study:

  • To outline strategies for perioperative antithrombotic drug management in thoracic surgery.
  • To provide guidance on drug cessation and resumption protocols.
  • To emphasize individualized patient assessment and adherence to guidelines.

Main Methods:

  • Review of current multisociety guidelines on antithrombotic therapy.
  • Analysis of risks associated with anticoagulant and antiplatelet agents in thoracic surgery.
  • Description of patient-specific management strategies.

Main Results:

  • Preoperative cessation and postoperative resumption of antithrombotics are critical.
  • Individualized assessment is necessary for optimal drug management.
  • Adherence to guidelines minimizes perioperative bleeding and thromboembolism.

Conclusions:

  • Optimal perioperative antithrombotic management is essential in thoracic surgery.
  • A tailored approach considering patient factors and guidelines improves safety.
  • Effective drug management reduces major bleeding and thromboembolic events.